Cargando…

Metabolic dysfunction-associated fatty liver disease in people living with HIV

The prevalence of metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) is high among people living with HIV (PLWH). Data on the recently proposed definition of metabolic dysfunction-associated fatty liver disease (MAFLD) in PLWH receiving antiretroviral therapy (ART) remains unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Michel, Maurice, Labenz, Christian, Armandi, Angelo, Kaps, Leonard, Kremer, Wolfgang Maximilian, Galle, Peter R., Grimm, Daniel, Sprinzl, Martin, Schattenberg, Jörn M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10244325/ https://www.ncbi.nlm.nih.gov/pubmed/37280241 http://dx.doi.org/10.1038/s41598-023-32965-y

Ejemplares similares

Effect of hepatic steatosis and associated metabolic comorbidities on health‐related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Prevalence and risk factors of nonalcoholic steatohepatitis with significant fibrosis in people with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Risk factors for poorer health literacy in patients with liver cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2021)

Evaluation of IL‐6 for Stepwise Diagnosis of Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Liver Frailty Index for Prediction of Short-Term Rehospitalization in Patients with Liver Cirrhosis
por: Kaps, Leonard, et al.
Publicado: (2022)

Validation of the Clinical Frailty Scale for the Prediction of Mortality in Patients With Liver Cirrhosis
por: Kremer, Wolfgang M., et al.
Publicado: (2020)

Elevated serum levels of methylglyoxal are associated with impaired liver function in patients with liver cirrhosis
por: Michel, Maurice, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and Depression
por: Labenz, Christian, et al.
Publicado: (2020)

Clinical Frailty Scale for risk stratification in patients with SARS-CoV-2 infection
por: Labenz, Christian, et al.
Publicado: (2020)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
por: Armandi, Angelo, et al.
Publicado: (2021)

Health-related quality of life in patients with autoimmune hepatitis
por: Michel, Maurice, et al.
Publicado: (2021)

Frailty as Tested by the Clinical Frailty Scale Is a Risk Factor for Hepatorenal Syndrome in Patients With Liver Cirrhosis
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Development and evaluation of a virtual reality driving test for patients with cirrhosis
por: Gairing, Simon J., et al.
Publicado: (2023)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Treatment of cytokine storm syndrome with IL‐1 receptor antagonist anakinra in a patient with ARDS caused by COVID‐19 infection: A case report
por: Kaps, Leonard, et al.
Publicado: (2020)

Influence of Advanced Organ Support (ADVOS) on Cytokine Levels in Patients with Acute-on-Chronic Liver Failure (ACLF)
por: Kaps, Leonard, et al.
Publicado: (2022)

Association Between Serum Levels of Neurofilament Light Chains and Minimal Hepatic Encephalopathy in Patients With Liver Cirrhosis
por: Labenz, Christian, et al.
Publicado: (2021)

The Role of p53 Dysfunction in Colorectal Cancer and Its Implication for Therapy
por: Michel, Maurice, et al.
Publicado: (2021)

Health literacy in gastrointestinal diseases: a comparative analysis between patients with liver cirrhosis, inflammatory bowel disease and gastrointestinal cancer
por: Kaps, Leonard, et al.
Publicado: (2022)

Cardiovascular Risk Categories in Patients With Nonalcoholic Fatty Liver Disease and the Role of Low‐Density Lipoprotein Cholesterol
por: Labenz, Christian, et al.
Publicado: (2019)

Portal vein thrombosis is associated with an increased risk of bone fractures
por: Gairing, Simon Johannes, et al.
Publicado: (2022)

Burden of depression and anxiety disorders per disease codes in patients with lymphoma in Germany
por: Tilch, Marie-Kristin, et al.
Publicado: (2021)

Portal Vein Thrombosis Is Associated with an Increased Incidence of Depression and Anxiety Disorders
por: Gairing, Simon Johannes, et al.
Publicado: (2021)

Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies
por: Labenz, Christian, et al.
Publicado: (2020)

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outside of intensive care
por: Kaps, L., et al.
Publicado: (2021)

Elevated serum levels of glial fibrillary acidic protein are associated with covert hepatic encephalopathy in patients with cirrhosis
por: Gairing, Simon Johannes, et al.
Publicado: (2023)

Impact of acute-on-chronic liver failure and decompensated liver cirrhosis on psychosocial burden and quality of life of patients and their close relatives
por: Nagel, Michael, et al.
Publicado: (2020)

A higher FIB‐4 index is associated with an increased incidence of renal failure in the general population
por: Schleicher, Eva Maria, et al.
Publicado: (2022)

Validation of the CLIF-C OF Score and CLIF-C ACLF Score to Predict Transplant-Free Survival in Patients with Liver Cirrhosis and Concomitant Need for Intensive Care Unit Treatment
por: Nagel, Michael, et al.
Publicado: (2023)

Sonographic assessment of low muscle quantity identifies mortality risk during COVID‐19: a prospective single‐centre study
por: Kremer, Wolfgang M., et al.
Publicado: (2021)

Continued alcohol consumption and hepatic encephalopathy determine quality of life and psychosocial burden of caregivers in patients with liver cirrhosis
por: Nagel, Michael, et al.
Publicado: (2022)

Suppressed serological vitamin A in patients with liver cirrhosis is associated with impaired liver function and clinical detoriation
por: Nagel, Michael, et al.
Publicado: (2022)

Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center “real-life” cohort
por: Steinebrunner, Niels, et al.
Publicado: (2015)

Hepatic interleukin‐1 receptor type 1 signalling regulates insulin sensitivity in the early phases of nonalcoholic fatty liver disease
por: Gehrke, Nadine, et al.
Publicado: (2022)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

Cost evaluation of PAGE-B risk score guided HCC surveillance in patients with treated chronic hepatitis B
por: Sprinzl, Martin F., et al.
Publicado: (2021)

Thyroid Diseases and Thyroid Asymptomatic Dysfunction in People Living With HIV
por: Micali, Cristina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_28ho0c0dcoo1u33rd6hu8p0ptv